[Retracted] High CHAF1A Expression Levels Are Positively-Correlated with PD-L1 Expression and Indicate Poor Prognosis in Gastric Cancer

Table 6

Multivariate cox regression analysis of 140 gastric cancer patients.

Factors	B-value	Multivariate analysis
		SE	Wald		HR (95% CI)
Sex
Male vs.female	0.59	0.393	2.257	0.133	1.804 (0.835–3.897)
Age (year)
≤ 60 vs.＞ 60	−0.179	0.297	0.363	0.547	0.836 (0.468–1.496)
CHAF1A expression
High vs. low	0.784	0.32	5.998	0.014	2.191 (1.170–4.105)
Family history (GC)
Yes vs. no	1.077	0.396	7.405	0.007	2.936 (1.352–6.377)
Smoking
Yes vs.no	−0.609	0.356	2.919	0.088	0.544 (0.271–1.094)
Drinking
Yes vs. no	0.254	0.372	0.464	0.496	1.289 (0.621–2.674)
Weight loss
Yes vs. no	0.007	0.310	0.000	0.983	1.007 (0.548–1.849)
Tumor location				0.164
Distal vs. proximal	0.427	0.353	1.465	0.226	1.533 (0.767–3.064)
Total vs. proximal	1.146	0.641	3.196	0.074	3.145 (0.895–11.044)
Borrmann type
I,IIvs.III,IV	0.831	0.327	6.45	0.011	2.295 (1.209–4.356)
Lauran type				0.712
Mixed vs. Intestinal	−0.266	0.332	0.638	0.424	0.767(0.400–1.471)
Diffuse vs. Intestinal	−0.039	0.452	0.008	0.931	0.961 (0.396–2.333)
Tumor size
≤ 5 cm vs.＞ 5 cm	−0.178	0.337	0.279	0.597	0.837 (0.433–1.619)
Pathological type
Adenocarcinoma vs. others	0.763	0.422	3.272	0.07	2.144 (0.938–4.900)
TNM stage
I,II vs. III,IV	−0.071	0.466	0.023	0.879	0.931 (0.374–2.322)
AFP (ng/ml)
≤ 8.1 vs.＞ 8.1	0.171	0.591	0.084	0.772	1.187 (0.373–3.777)
CA199 (U/ml)
≤ 37 vs.＞ 37	0.254	0.329	0.595	0.44	1.289 (0.676–2.459)
CA125 (U/ml)
≤ 35 vs. ＞ 35	1.079	0.464	5.392	0.02	2.941 (1.183–7.308)
HER2
Negative vs.positive	0.093	0.436	0.045	0.831	1.098 (0.467–2.582)
PD-L1
Negative vs.positive	0.096	0.296	0.105	0.746	1.101 (0.616–1.968)

Statistically significant ().